Tests a wearable device for remotely monitoring people with COPD
Explores whether a wearable device can remotely monitor adults with COPD flare-ups.
Plain-language title generated from the registry record
Registry title: The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 1
Key facts
- Where
- Glasgow, United KingdomSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a current diagnosis of COPD who can use a smartphone or computer. It tests remote monitoring with a wearable device.
- Age
- 18 years or over
- Sex
- All sexes can join
- Disease stage
- Current diagnosis of COPD. No flare-up (acute exacerbation) of COPD in the 6 weeks before joining.
- Earlier treatment
- No lung surgery in the last 6 months. No high-dose oral steroids (10 mg or more of prednisolone a day) for more than 3 months in a row. No long-term oxygen therapy.
Main reasons for not taking part
- Another lung disease that is the main cause of symptoms (for example asthma, lung cancer, tuberculosis)
- Severe alpha-1-antitrypsin deficiency
- Cancer or another terminal condition with 12 months or less to live, in the investigator's opinion
- Pregnancy
- Already in another research study, or in a clinical trial in the last 3 months
Read by machine on 9 November 2026.
Where in United Kingdom
- Oakview Medical Practice in AlexandriaGlasgow, United KingdomNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Strathclyde
- Trial code
- NCT06419036
- Record updated
- 10 April 2025
- Original description
The proposed study will explore whether remote monitoring of a COPD patient can be undertaken using a wearable medical device.Read full original descriptionShow less
The Use of Medical Devices to Monitor COPD Patients Study - An Observational Feasibility Study
The proposed study will explore whether remote monitoring of a COPD patient can be undertaken using a wearable medical device.
Inclusion: Any person aged 18 years or over; Current diagnosis of COPD; Be willing and able to comply with study procedures and be available for study visits. • Be able to use a 'smartphone or computer'; Be able to give written consent; Able to understand written and spoken English.
Exclusion: Having undergone lung surgery (e.g. lung volume reduction, lobectomy) within the last 6 months; Taking high-dose oral corticosteroid medication (equivalent to daily dose of ≥10 mg of prednisolone) for more than 3 consecutive months; Participation in an interventional clinical study within 3 months of Visit 1 or participation in a study using an investigational medicinal product (IMP) either in the previous 3 months or in the interval from last using the IMP to 5 times its half-life; On long-term oxygen therapy; Acute exacerbation of COPD within 6 weeks prior to inclusion; Known respiratory disorders are other than COPD which, in the opinion of the investigator, is the main contributor to the patient's symptoms (e.g. asthma, lung cancer, sarcoidosis, and other interstitial lung diseases (ILDs), tuberculosis, lung fibrosis, cystic fibrosis, and non-COPD related bronchiectasis); Known history of significant systemic and other organ-related diseases, other than COPD, which in the opinion of the investigator, is likely to interfere with the study or impact on subject safety (e.g. severe rheumatoid arthritis and Lupus, kidney, liver, endocrine, psychological disorders); Have cancer or other terminal condition which, in the opinion of the investigator, has a mortality of 12 months or less. • Have, in the opinion of the investigator, evidence of alcohol, drug or solvent abuse; Patients with other significant lung disease, unable to consent, unable to use the technology (e.g. inability to use the data device, or complete the questionnaires), or at the clinician's discretion for other more significant medical/social reasons; Known allergy to surgical adhesive tape; Inability to give written informed consent; Known to be severely alpha-1-antitrypsin deficient (PI, SZ or ZZ); Based on their medical record if there is any social violence/substance misuse; Pregnancy; Patients already involved in an ongoing research study.